Oncimmune Holdings Past Performance

How has Oncimmune Holdings performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-4.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ONC is currently unprofitable.

Growing Profit Margin: ONC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ONC is unprofitable, and losses have increased over the past 5 years at a rate of 4.3% per year.

Accelerating Growth: Unable to compare ONC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ONC is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.1%).


Return on Equity

High ROE: ONC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Discover strong past performing companies